TYK Medicines, Inc

TYK Medicines, Incverified

2410.HK

Price:

$13.95

Market Cap:

$4.76B

TYK Medicines, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, acquisition, development, and commercialization of therapies to address unmet medical needs in cancer treatment. Its lead product candidate is TY-9591, a third-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor for the treatment of brain metastases from non-small cell lung cancer (NSCLC) with EGFR mutations, and in locally advanced or metastatic NSCLC with EGFR L858R mutation. The company also develops TY-302, an oral cyclin-dependent kinase (CDK) 4/6 inhibitor to treat solid tumors, including breast cancer and prostate cancer; TY-2136b, an oral ROS proto-oncogene 1/neurotroph...[Read more]

Industry

Drug Manufacturers - General

IPO Date

Stock Exchange

HKSE

Ticker

2410.HK

The PE Ratio as of December 2025 (TTM) for TYK Medicines, Inc (2410.HK) is -16.81

According to TYK Medicines, Inc’s latest financial reports and current stock price. The company's current PE Ratio is -16.81. This represents a change of 50.97% compared to the average of -11.13 of the last 4 quarters.

TYK Medicines, Inc (2410.HK) Historical PE Ratio (quarterly & annually)

How has 2410.HK PE Ratio performed in the past?

The mean historical PE Ratio of TYK Medicines, Inc over the last ten years is -21.70. The current -16.81 PE Ratio has changed 7.65% with respect to the historical average. Over the past ten years (40 quarters), 2410.HK's PE Ratio was at its highest in in the December 2023 quarter at -10.06. The PE Ratio was at its lowest in in the March 2023 quarter at -13.38.

Quarterly (TTM)
Annual

Average

-21.70

Median

-14.42

Minimum

-38.64

Maximum

-12.04

TYK Medicines, Inc (2410.HK) PE Ratio by Quarter and Year

Discovering the peaks and valleys of TYK Medicines, Inc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 220.98%

Maximum Annual PE Ratio = -12.04

Minimum Annual Increase = -16.55%

Minimum Annual PE Ratio = -38.64

Quarterly (TTM)
Annual
YearPE RatioChange
2024-38.64220.98%
2023-12.04-16.55%

TYK Medicines, Inc (2410.HK) Average PE Ratio

How has 2410.HK PE Ratio performed in the past?

The current PE Ratio of TYK Medicines, Inc (2410.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-21.70

5-year avg

-21.70

10-year avg

-21.70

TYK Medicines, Inc (2410.HK) PE Ratio vs. Peers

How is 2410.HK’s PE Ratio compared to its peers?

TYK Medicines, Inc’s PE Ratio is less than Tong Ren Tang Technologies Co. Ltd. (12.63), greater than Jacobio Pharmaceuticals Group Co., Ltd. (-123.33), greater than Qyuns Therapeutics Co., Ltd. (-21.57), less than VISEN Pharmaceuticals (-14.52), greater than Jiangxi Rimag Group Co., Ltd. (-102.35), less than China Shineway Pharmaceutical Group Limited (6.98), less than AIM Vaccine Co., Ltd. (-13.76), less than Shanghai Kindly Medical Instruments Co., Ltd. (25.00), greater than Ocumension Therapeutics (-23.72), greater than Yidu Tech Inc. (-42.67),

Build a custom stock screener for TYK Medicines, Inc (2410.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TYK Medicines, Inc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

TYK Medicines, Inc (2410.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like TYK Medicines, Inc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is TYK Medicines, Inc's PE Ratio?

How is the PE Ratio calculated for TYK Medicines, Inc (2410.HK)?

What is the highest PE Ratio for TYK Medicines, Inc (2410.HK)?

What is the 3-year average PE Ratio for TYK Medicines, Inc (2410.HK)?

What is the 5-year average PE Ratio for TYK Medicines, Inc (2410.HK)?

How does the current PE Ratio for TYK Medicines, Inc (2410.HK) compare to its historical average?